Go to homepage
     
Home
Who we are
>company profile
>career opportunities
>mission and pledge
>caring for community
what we do
>Oral Health Care
>Biotechnology
  r & d
  > Oral Health Diagnostics
    Halitosis
    Periodontitis
  >Neurodegenerative Diagnostic
   
  product
  >Nucleotide Photoaffinity Labeling
  >TOPAS
   
  What's New
  >In the News
   
  Contact Us
  >order products
  >Customer Service
  >Human Resources
  >Investment Opportunities

We have dedicated ourselves to research and innovation of dental and medical products and other related services. Research is revealing a possible relationship between oral health and systemic diseases such as cardiovascular, stroke, diabetes and preterm delivery.

As there’s growing awareness of a possible oral-systemic connection, there’s a stronger call to action for a healthy mouth and the need for cutting-edge technology and public awareness to improve overall well-being.

As a strong body of evidence suggests that infection from the oral cavity may increase the risk and complications for a number of serious diseases and conditions, patient education and awareness is important.

ALT BioScience’s TOPAS™ and was specifically developed to help improve general health by bringing to market cutting-edge science that addresses significant unmet healthcare needs. As a research use only tool, it has provided market and development feedback for a next-generation oral care product.

As emerging dentistry and medical professionals seek to further define these interrelationships through scientific inquiry, ultimately, this new knowledge may prove useful in intervention strategies to reduce patient risks and prevent systemic disease outcomes.

With increasing knowledge of oral disease patterns and treatment options, it is expected that future clinical practice may incorporate diagnostic based data into treatment plans along with prognosis for dental treatment.

By providing healthcare professionals with excellent products and services, it is in our pledge to be defined by excellence with a promise of commitment for continued innovation with uncompromised quality and services we provide.

“Today, there’s more knowledge on oral health and possible systemic disease connections. Being on the forefront of emerging dentistry and the bridge to the medical community is an exciting and challenging opportunity. The intrinsic value of the products and services we provide ensures we have a critical role to play in serving provider and patient needs and sets the stage for growth and strong financial performance for years to come."

Leslie J. Herzog
Chairman and Chief Executive Officer